Medical Cannabis for Fibromyalgia: Success Rate and Top Brands
Discover the success rate of medical cannabis in treating fibromyalgia and find top cannabis brands for THC products online.
Fibromyalgia is a chronic pain condition. CDC data puts US prevalence at about 2% of adults, or 4 million people. Cannabis is not FDA-approved for fibromyalgia. No product carries that label. A pain clinician can confirm the diagnosis and complete state paperwork in states where medical cannabis is legal.
medical cannabis for fibromyalgia symptoms
Research is thin. A 2011 randomized trial tested nabilone, a synthetic THC analog, in 40 people with fibromyalgia. Participants reported less pain and less anxiety than the placebo group. The trial was small. A 2021 review of cannabinoids for chronic pain found modest benefit and low-quality evidence. CBD alone has no strong trial data for fibromyalgia pain.
Common effects: drowsiness, dry mouth, dizziness, short-term memory problems. THC raises heart rate. Cannabis can interact with opioids, benzodiazepines, and warfarin. Do not drive after use. Avoid cannabis in pregnancy.
medical cannabis for fibromyalgia dosage
No long-term trial of cannabis in fibromyalgia exists. The best ratio, the dose ceiling, and the effect on flare frequency are unmeasured. State programs differ on qualifying conditions. Some states list chronic pain. Others list fibromyalgia by name.